NewsBenzingaXylem Lowers FY2026 Adj EPS Guidance from $5.55-$5.70 to $5.40-$5.45 vs $5.66 Est; Lowers FY2026 Sales Guidance from $9.200B to $8.950B vs $9.191B Est Xylem Lowers FY2026 Adj EPS Guidance from $5.55-$5.70 to $5.40-$5.45 vs $5.66 Est; Lowers FY2026 Sales Guidance from $9.200B to $8.950B vs $9.191B Est Benzinga 2026.10.27 10:55 (GMT+0) Open on Benzinga Other news Nvidia’s $105 Billion OpenAI Bet Has a 20-Year Catch Freedom Broker Upgrades Espey Manufacturing to Buy, Maintains Price Target to $70 QUICK SPARK: Chip Stocks Eye Worst Two-Month Drop Since 2008 Carlyle, Clearlake Bet Big On Sports — And PE Deals Are Surging Target's $301 Million Tariff Windfall 'Flattered' Earnings, Analyst Says Freedom Broker Maintains Buy on SKYX Platforms, Lowers Price Target to $2